Fabiana Gentilini
- Hematology top 5%
- Multiple Myeloma Research and Treatments 11
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 2
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Ophthalmology top 10%
-
- Protein Degradation and Inhibitors 7
-
- Peptidase Inhibition and Analysis 6
-
- Natural Compounds in Disease Treatment 3
- Co-authors
- Massimo BrecciaRoberto LatagliataIda CarmosinoGiuliana AlimenaFranco MandelliGiuseppe CiminoAnna GuariniFrancesco Lo‐Coco
- Cited by
- HematologyGeneticsInternal Medicine
- Partner nations
- ItalyNetherlandsMalaysia
In The Last Decade
Fabiana Gentilini
20 papers receiving 289 citations
Peers
Comparison fields: 5 of 39
- Hematology 232
- Genetics 91
- Internal Medicine 28
- Biochemistry 37
- Ophthalmology 28
Countries citing papers authored by Fabiana Gentilini
This map shows the geographic impact of Fabiana Gentilini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabiana Gentilini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabiana Gentilini more than expected).
Fields of papers citing papers by Fabiana Gentilini
This network shows the impact of papers produced by Fabiana Gentilini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabiana Gentilini. The network helps show where Fabiana Gentilini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fabiana Gentilini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (WKCYD) FOLLOWED BY MAINTENANCE WITH WEEKLY CARFILZOMIB (WK) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) | 2016 | 2 |
| 3 | 2015 | 1 | |
| 4 | 2015 | 4 | |
| 5 | 2014 | 11 | |
| 6 | 2014 | 5 | |
| 7 | 2013 | 7 | |
| 8 | 2012 | 4 | |
| 9 | 2012 | 10 | |
| 10 | 2012 | 19 | |
| 11 | 2012 | 23 | |
| 12 | 2009 | 9 | |
| 13 | 2007 | 5 | |
| 14 | 2007 | 1 | |
| 15 | 2007 | 31 | |
| 16 | 2006 | 26 | |
| 17 | 2006 | 90 | |
| 18 | 2006 | 6 | |
| 19 | 2005 | 17 | |
| 20 | 2004 | 9 |
About Fabiana Gentilini
Fabiana Gentilini is a scholar working on Hematology, Genetics and Complementary and alternative medicine, having authored 22 papers that have together received 296 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Natural Compounds in Disease Treatment (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Hematology (232 citations), Genetics (91 citations) and Internal Medicine (28 citations). Fabiana Gentilini has collaborated with scholars based in Italy, Netherlands and Malaysia. Frequent co-authors include Massimo Breccia, Roberto Latagliata, Ida Carmosino, Giuliana Alimena, Franco Mandelli, Giuseppe Cimino, Anna Guarini, Francesco Lo‐Coco, Maria Stefania De Propris and M C Petti. Their work appears in journals such as Blood, Leukemia Research, Cancer, Patient Preference and Adherence and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.